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Abstract
Background: The use of dietary supplements and over-the-counter (OTC) drugs is increasing, and there is adequate
concern about potential harmful effects. However, there are limited reports on the concurrent use of nonprescription
medications with prescription medications in elderly patients. Therefore, this study was conducted to describe the use
of dietary supplements and OTC drugs, and to identify predictors for their use in elderly patients using medications
prescribed for chronic diseases.
Methods: This was a cross-sectional study that enrolled 729 patients aged ≥65 years with chronic diseases, between
January and March 2016. Data regarding socio-demographic status, medical condition, number of prescriptions, use of
nonprescription medications, and psychological status were collected using a self-administered questionnaire and by
review of medical records. Data regarding use of dietary supplements and OTC drugs were analyzed using descriptive
statistics. Logistic regression analysis was applied to investigate factors associated with the use of dietary supplements
and OTC drugs.
Results: The regular use of nonprescription drugs was reported by 32.5% of patients. Vitamins were the most
commonly used dietary supplements in elderly patients. Female sex, higher educational qualifications, and good
economic status were identified as predictors for the use of nonprescription medications. Concurrent use of
nonprescription medications with more than 5 prescription medications was detected in 12.2% of participants.
The disclosure rate of the use of nonprescription medications by patients to the physician was 30.3%.
Conclusion: The use of dietary supplements and OTC drugs was common in elderly patients with chronic diseases, and
its use is associated with sex, education, and economic status. General practitioners (GPs) need to recognize the potential
use of nonprescription medications, considering that polypharmacy was common and disclosure rate was low in this study.
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Background
Recent studies have shown that the prevalence of over-
the-counter (OTC) medications and use of dietary sup-
plements in older adults is increasing [1, 2]. The use of
such drugs and products by elderly patients with chronic
diseases needs to be particularly considered, because the
drug metabolism in these patients is deteriorated due to
their age. Nevertheless, concurrent use of nonprescrip-
tion medications with prescription medications is com-
mon according to a study conducted in the United
States (U.S.) [3]. It is difficult for medical practitioners
to know the use of nonprescription medications as these
are used at the discretion of the patients. In addition,
previous reports suggested that many patients taking
nonprescription medication do not tend to disclose the
use of these drugs to their physician [4, 5].
A systematic review about self-medication in the eld-
erly population reported that the prevalence of self-
medication varied between 4 and 87%, and was associ-
ated with female sex, visits to pharmacists, depression,
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functional dependency, recent hospitalization, oral pain,
restriction of activities and physical inactivity [6]. Another
research study conducted in the U.S. reported that factors
associated with dietary supplement use in patients taking
prescription medication were female sex, Hispanic ethni-
city, higher education, lack of medical insurance, and
chronic conditions [7]. While depression was associated
with the use of complementary medications in cancer pa-
tients [8], only one study reported the association of de-
pression with the use of multiple nonprescription
medications in the elderly population [9]. Overall, the as-
sociation of anxiety or depression with the use of nonpre-
scription medications was not well assessed in previous
studies in elderly patients with chronic diseases.
Most of the previous studies on the use of nonpre-
scription medications were conducted in a limited
amount of countries and with areas mainly in the U.S.
or Brazil, and reports from Asian countries are few. The
use of nonprescription medications can be different per
country and area, as it is dependent on the access to
medical care, health system, and cultural differences.
However, the use of dietary supplements and OTC med-
ications and the predictors for its use are not well stud-
ied in Japanese elderly patients.
In this study, we aimed to describe the use of nonpre-
scription medications including dietary supplements and
OTC medications, and additionally identify the predic-
tors for its use in elderly patients who use prescription
medications for chronic diseases in Japan. We also hy-
pothesized that depression or anxiety is associated with
the use of nonprescription medications.
Methods
Study design and setting
This was a cross-sectional study conducted in an out-
patient clinic at the Family Medicine department of an
urban general hospital in Tokyo, Japan. Patients aged
≥65 years with chronic diseases who had at least one
prescription medication were recruited between January
and March 2016. Patients who met the following criteria
were included in the study: age ≥ 65 years, presence of
chronic diseases, and use of at least one prescription
medication (excluding topical drugs). Written informed
consent was obtained from each participant and those
who did not consent to the study were excluded. Pa-
tients younger than 65 years, and patients with difficulty
in communicating in Japanese were excluded.
Data collection
Data from electronic medical records and responses to
the questionnaire were used to obtain information about
the patients’ characteristics including age, sex, estimated
glomerular filtration rate (mL/min/1.73 m2), subjective
economic status, educational qualifications, Hospital
Anxiety and Depression Scale (HADS) score, use of non-
prescription medications, and disclosure of the use to a
physician. According to the common definition [10],
polypharmacy in our study was defined as prescription
of more than 5 drugs. Comorbidity was assessed using
the Charlson Comorbidity Index (CCI), with the infor-
mation obtained from the patients’ medical records and
the questionnaire survey. The CCI was developed in
1987 and has been used since as a tool to assess the se-
verity of chronic diseases [11]. The HADS was used to
study the relationship between psychological status and
the use of nonprescription medications. The HADS was
developed by Zigmond and has been used worldwide to
measure anxiety and depression in patients with chronic
diseases [12]. It consists of 14 items divided between 2
question groups, one on anxiety, and one on depression,
with each question rated from 0 to 3. A Japanese version
was validated in a previous study [13]. We used a score
of 8 points as a cut-off for both evaluation of anxiety
and depression, i.e., patients with a score of 8 points or
more on the anxiety or depression scales, were identified
as anxious and depressed, respectively.
Outcome measurements
Questions about current use of nonprescription medica-
tions were part of the questionnaire (“Currently, do you
regularly use OTCs, dietary supplements, healthy foods,
or herbal medicine other than prescriptions by doc-
tors?”), Of those who answered yes, respondents were
asked the type of nonprescription medications, divided
into 4 categories, i.e., OTC medications, dietary supple-
ments including vitamins and healthy foods, herbal med-
icines and others. There was no definition for dietary
supplements in Japan, therefore we defined them as “A
dietary supplement is a product intended for ingestion
that contains a "dietary ingredient" intended to add fur-
ther nutritional value to (supplement) the diet.” using
definition by U.S. Food and Drug Administration (FDA)
[14]. Patients who use nonprescription medications
regularly were asked whether they had disclosed the use
to their physician (“Have you told to your doctor that
you have been using OTCs, dietary supplements, healthy
foods, or herbal medicine other than prescriptions by
doctors?”.
Statistical analysis
Descriptive data are presented by mean and standard devi-
ation (SD) for normally distributed continuous variables,
and by median and interquartile range (IQR) for non-
parametric variables. Categorical data are presented as
number and percentage. The percentage of categorical vari-
ables were compared using χ2 tests. Variables with a P value
below 0.10, anxiety and depression were used for logistic
regression analysis to assess the association between each
Masumoto et al. BMC Family Practice  (2018) 19:20 Page 2 of 7
independent variable and the use of nonprescription medi-
cations. The results of the logistic regression analysis are
presented with odds ratios (ORs) and 95% confidence inter-
vals (CIs). A P value below 0.05 was considered to be statis-
tically significant. All statistical analyses were performed
using IBM SPSS ver. 22 (IBM Corp., Armonk, NY, USA).
Results
Background data of patients
A total of 729 patients were included in the analysis.
Basic characteristics of participants are shown in Table 1.
The mean age and ± SD of participants was 75.6 ±
7.5 years, and 51.6% of the population were women. The
median number of prescription medications that was
taken per patient was 4 (IQR 2–6) with a range of 1–22.
Polypharmacy in patients in this study was 39.3%. The
percentages of patients with a depressive mood and anx-
iety, who scored 8 points or more by the HADS, were
23.1% and 16.1%, respectively. Underlying medical con-
ditions are shown in Table 2. The median CCI was 1
(IQR 0–1), which indicates that many participants had
relatively mild diseases.
The use and details of nonprescription medications
Overall, 237 (32.5%) patients reported the use of nonpre-
scription medications. Reported drugs and products were
categorized into dietary supplements (28.0%), OTC medica-
tions (9.1%), and herbal medicines (3.6%). Vitamins and
minerals, aojiru (green juice), and chondroitin-glucosamine
were common in dietary supplements (Table 3). Of OTC
drugs, digestives and laxatives were commonly used. The
percentage of patients using herbal medicine was low. Only
72 (30.4%) patients disclosed the use of nonprescription
medications out of 237 patients actually using them.
Predictors for the use of nonprescription medication
Univariate analysis showed that female sex, educational
qualifications higher than high school, and good eco-
nomic status were associated with the use of nonpre-
scription medications. Anxiety and depression defined
by the HADS score were not significantly associated
with the use of nonprescription medications (Table 4).
Female sex (Adjusted OR = 1.55, 95% CI = 1.01–2.37),
educational qualifications higher than high school (Ad-
justed OR = 1.43, 95% CI = 1.14–2.44), and good eco-
nomic status (Adjusted OR = 1.63, 95% CI = 1.08–2.46)
were associated with the use of nonprescription medica-
tion on multivariable analysis, but neither anxiety nor
depression were directly associated with the use of non-
prescription medications (Table 5).
Subgroup analyses were conducted each for dietary sup-
plements and OTC drugs. In logistic regression analysis
which assessed factors related to the use of dietary supple-
ments, it was shown that female sex (Adjusted OR = 1.61,
95% CI = 1.03–2.51) and higher educational attainment
(Adjusted OR = 1.73, 95% CI = 1.16–2.58) were signifi-
cantly associated the use of dietary supplements, though
lower economic status did not reach at a significant level
(Adjusted OR = 1.47, 95% CI = 0.96–2.24). In logistic re-
gression analysis which assessed factors related to OTC
Table 1 Characteristics of the Study Population
Characteristics Total (n = 729)
Age, mean ± SD 75.6 ± 7.5
Sex, n (%)
Male 353 (48.4)
Female 376 (51.6)
Drug prescriptions per patient, median (IQR) 4 (2–6)
Charlson comorbidity index, median (IQR) 1 (0–1)
Smoking status, n (%)
Current smoker 70 (9.6)
Past smoker 285 (39.3)
Never smoker 371 (51.1)
Regular drinker, n (%) 238 (32.8)
Lives alone, n (%) 187 (26.3)
Economic status, n (%)
Less than average 122 (17.1)
Average 442 (62.0)
More than average 149 (20.9)
Educational qualification, n (%)
≦High school 282 (40.3)
> High school 417 (59.7)
Anxiety by HADS, n (%) 106 (16.1)
Depression by HADS, n (%) 154 (23.1)
Missing values were omitted from percentage calculation
SD Standard deviation, IQR Interquartile range, HADS Hospital Anxiety and
Depression Scale
Table 2 Underlying Medical Conditions of Patients
Underlying medical conditions n (%)
Hypertension 525 (72.0)
Hyperlipidemia 374 (51.3)
Chronic Kidney Disease (eGFR < 50 mL/min/1.73m2) 153 (21.0)
Diabetes mellitus 150 (20.6)
Hyperuricemia/gout 138 (18.9)
Cerebrovascular disease 130 (17.8)
Respiratory disease (Bronchial Asthma, COPD) 86 (11.8)
Gastric ulcer 94 (12.9)
Dementia 57 (7.8)
Cardiovascular disease 51 (7.0)
Liver disease 39 (5.3)
COPD Chronic Obstructive Pulmonary Disease
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use, it was shown that only female sex (Adjusted OR =
1.61, 95% CI = 1.03–2.51) was associated with the OTC
use. Although the other variables showed no significant
association with OTC use because of the small number of
subjects (n = 59), there was a similar tendency in dietary
supplements users and OTC users [see Additional file 1].
Polypharmacy and nonprescription medications
Patients who were prescribed more than 5 drugs
accounted for 39.5% of the participants. Of all partici-
pants, 89 (12.2%) patients were concurrently using non-
prescription medications with more than 5 prescription
medications. Polypharmacy and the use of nonprescrip-
tion medication were not significantly associated signifi-
cantly on univariate analysis.
Discussion
The use of dietary supplements and OTC drugs was com-
mon in elderly patients with chronic diseases, and its use
is associated with female sex, higher education, and good
economic status. Concurrent use of nonprescription
Table 3 Frequency of nonprescription medication use and
details (n = 237)
Nonprescription medications n (%)
Dietary supplements 204 (28.0)
Vitamin/minerals 48 (6.6)
Calcium 16 (2.2)
Vitamin C 12 (1.6)
Vitamin E 4 (0.5)
Any vitamin B 21 (2.9)
Chondroitin-glucosamine 29 (4.0)
Omega-3 fatty acids 9 (1.2)
Zinc 5 (0.7)
Aojiru (Green juice) 30 (4.1)
Coenzyme Q-10 3 (0.4)
Probiotics 8 (1.1)
Sesamin 12 (1.6)
Garlic 10 (1.4)
Hyaluronic acid/Collagen 15 (2.1)
Propolis/Royal Jerry 13 (1.8)
Vinegar 5 (0.7)
Blueberry, Carotenoids 13 (1.8)
Amino acids, Proteins 6 (0.8)
Combined natural products 24 (3.3)
Enzymes 9 (1.2)
Others 11 (1.5)
OTCs 66 (9.1)
Digestives 27 (3.7)
Laxative 14 (1.9)
Analgesics 5 (0.7)
Antihistamines 3 (0.4)
Herbal medicines 26 (3.6)
Not reported 39 (5.3)
Table 4 Association between each variable and the use of
nonprescription medications by univariate analysis
Variables Nonprescription
medication use
P value
Yes: n, (%) No: n, (%)
Sex 0.013
Male 99 (28.0) 254 (72.0)
Female 138 (36.7) 238 (63.3)
Age 0.030
< 75 133 (36.2) 234 (63.8)
≧75 104 (28.7) 258 (71.3)
Number of prescription medications 0.454
≦4 148 (33.6) 293 (66.4)
≧5 89 (30.9) 199 (69.1)
CCI 0.312
0–1 184 (33.5) 365 (66.5)
≧2 53 (29.4) 127 (70.6)
Smoking status 0.017
Current smoker 16 (22.9) 54 (77.1)
Past smoker 83 (29.1) 202 (70.9)
Never smoker 138 (37.2) 233 (62.8)
Drinking habit 0.951
Regular drinker 77 (32.4) 161 (67.6)
Non drinker 159 (32.6) 329 (67.4)
Family member 0.376
Lives alone 65 (34.8) 122 (65.2)
Lives with other
family members
164 (31.2) 361 (68.8)
Economic status 0.002
Less than average 34 (27.9) 88 (72.1)
Average 133 (30.1) 309 (69.9)
More than average 67 (45.0) 82 (55.0)
Educational qualification 0.003
≦High school 76 (27.0) 206 (73.0)
> High school 157 (37.6) 260 (62.4)
Anxiety by HADS 0.508
≦7 180 (32.5) 373 (67.5)
≧8 38 (35.8) 68 (64.2)
Depression by HADS 0.484
≦7 168 (32.7) 346 (67.3)
≧8 55 (35.7) 99 (64.3)
Missing values were omitted from percentage calculation
CCI Charlson Comorbidity Index, HADS Hospital Anxiety and Depression Scale
Masumoto et al. BMC Family Practice  (2018) 19:20 Page 4 of 7
medications with more than 5 prescription medications
was not uncommon, but the disclosure rate to the phys-
ician was low.
This study showed that 32.5% of Japanese elderly patients
with prescription medications for chronic diseases concur-
rently used nonprescription medication. Previous studies
have reported that the use of nonprescription medications
is 16.6–66% in the elderly population [15–18], and 20.2–
71.4% in the general population [19–21]. The percentage
of patients using nonprescription medication in the present
study is consistent with previous reports. However, the per-
centage in our study may be higher than in the general eld-
erly population as all the participants in the present study
have chronic diseases with prescription medications.
The present study also demonstrated that dietary sup-
plements are the most commonly used nonprescription
medications. Among dietary supplements, vitamins and
minerals were the most frequently used, followed by
aojiru (green juice) and chondroitin-glucosamine. One
study conducted in a hospital in Tokyo reported that
health foods including dietary supplements and herbal
medicine were commonly used as complementary and
alternative medicine (CAM) [22]. Compared to a U.S.
report, non-vitamin dietary supplements were different
in our study. Echinacea, Ginseng, Ginkgo biloba, and St
John’s wort were reported to be popular in the U.S. [7],
but such products were not commonly used in the
present study. Vitamins and minerals are universally
common supplements but other supplements can vary
per country and region, thereby reflecting the differences
in health system, OTC medications approval, and cul-
ture. Aojiru (Green juice), a juice of mixed green vegeta-
bles, is very popular in Japan. It is usually not harmful
for healthy adults, but it can be risky for patients with
chronic kidney disease, as it is enriched with potassium.
Chondroitin-glucosamine is one of the most popular
supplements in the world, as many elderly patients have
orthopedic problems. In this study, use of OTC medica-
tions and herbal medicine was less frequent than previ-
ously reported in Japan. The reason for this may be that
the clinic provides mainly conventional medicines and
the patients who prefer to use OTC medications or
herbal medicines do not come to the clinic.
Predictors for the use of nonprescription medica-
tions were consistent with previous studies. Female
sex [2, 7, 15, 19, 21, 23], younger age [2, 16], higher educa-
tional qualifications [7, 15, 23], lower income [24], higher
income [16], absence of smoking habits [15], living alone
[15, 18], retirement [15], and chronic conditions [7] have
been reported to be associated with the use of dietary sup-
plements or OTC medications. Contrary to our hypoth-
esis, anxiety, depression, and polypharmacy were not
associated with the use of nonprescription medications.
Concurrent use of nonprescription medications with
more than 5 prescription medications was frequent in as
much as 12.2% of participants. Previous studies also
demonstrated high numbers of patients on concurrent
use of nonprescription and prescription medications [3,
25, 26]. Elderly patients with chronic diseases are at high
risk of drug-drug interaction due to the concurrent use
of medications. Research from the U.S. reported the po-
tential interaction between some nonprescription and
prescription medications, especially with anticoagulant
and antiplatelet therapies [3, 27]. However, one study re-
ported that the actual potential for harm by interaction
between prescription medications and dietary supple-
ments was low [28]. In Japan, the risks of interaction be-
tween nonprescription medications and prescription
medications may be different from other countries be-
cause St John’s wort, ginseng, ginkgo, or garlic, which
can interact with anticoagulant and antiplatelet therap-
ies, were rarely used in this study.
The percentage of patients given disclosure about their
use of nonprescription medications to the physician was
low. According to previous studies, 33% to 48.6% of pa-
tients taking dietary supplements disclosed this to a
healthcare provider [15, 29]. Non-disclosure rates of
CAM including dietary supplements were 29% to 77%
according to one review [30], recent studies also sup-
ported the previous results and questions about the use
by a medical practitioner was a major predictor of dis-
closure [31–33]. It is important to collect all information
about nonprescription medications considering the po-
tential risk of drug-drug interactions. Medical practi-
tioners should recognize the potential use of dietary
supplements and try to ask patients whether they use
nonprescription medications. Education for both med-
ical practitioners and patients would be important to in-
crease the disclosure rate. In addition, patients that use
dietary supplements should know the potential harm
and need to ask doctors if they can take the product,
Table 5 Factors associated with the use of nonprescription
medications by logistic regression analysis (n = 623)
Variables Univariate Multivariate P value
Crude OR
(95% CI)
Adjusted OR
(95% CI)
Female sex 1.47 (1.08–2.02) 1.58 (1.03–2.41) 0.036
Age≧75 0.72 (0.52–0.98) 0.78 (0.55–1.11) 0.171
Education > high school 1.68 (1.21–2.34) 1.70 (1.16–2.49) 0.007
Economic status (ref. = average)
Less than average 1.09 (0.70–1.70) 1.20 (0.72–1.99) 0.484
More than average 1.89 (1.30–2.77) 1.62 (1.07–2.43) 0.021
Never smoker 1.48 (1.08–2.03) 1.23 (0.81–1.88) 0.330
Anxiety by HADS 1.17 (0.76–1.80) 1.27 (0.77–2.10) 0.350
Depression by HADS 1.05 (0.72–1.54) 1.23 (0.79–1.91) 0.367
HADS0 Hospital Anxiety and Depression Scale
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especially elderly patients with chronic diseases who use
prescribed drugs.
There are some limitations in the present study. First,
this study was conducted at a single facility, so selection
bias could have happened. The use of nonprescription
medications may be higher in Tokyo than other areas,
because the average income in Tokyo is higher than in
other areas in Japan. Secondly, there is a possibility of
underreporting the use of nonprescription medications,
as this study was conducted using a self-administered
questionnaire. The rate of reporting the use of supple-
ments through a self-administered questionnaire was
demonstrated to be very low [34], but previous studies
were also mainly conducted by questionnaires and our
data is therefore comparable with others.
As a result, we reported the use and details of nonpre-
scription medications in elderly patients with chronic
diseases and its predictors, which are relatively new find-
ings for Asian countries. Further research is needed to
examine the relationship between the use of nonpre-
scription medications and actual harm by interactions
caused by concurrent use of nonprescription medica-
tions and prescription medications.
Conclusions
Our results show that the use of nonprescription medica-
tions was common in elderly patients with chronic dis-
eases. The type of the nonprescription medications were
mainly dietary supplements including vitamins/minerals,
aojiru (green juice), and chondroitin-glucosamine. Female
sex, higher educational qualifications, and good economic
status were associated with the use of nonprescription
medications. Concurrent use of nonprescription and pre-
scription medications, even with more than 5 prescription
medications, were common in elderly patients, and the dis-
closure rate of the use of nonprescription medications was
low. Therefore, medical practitioners should ask about the
use of nonprescription medications and assess the potential
drug-drug interaction with prescription medications.
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